Nurse Practitioners Taking the Lead in Colorectal Cancer Screening

Study shows high level of awareness throughout profession

On Tuesday, Exact Sciences announced results of HealthyWomen’s National Colorectal Cancer Screening Knowledge and Practice Patterns (SNAPP) Survey in partnership with the American Association of Nurse Practitioners (AANP).

This survey of over 350 nurse practitioners (NPs) showed the profession is highly engaged in colorectal cancer (CRC) screening of patients. The study also revealed the need for increased awareness of the multitarget stool DNA test, a recommended CRC screening option.

Over 90 percent of NPs aged 50 years and older who were surveyed reported being screened for CRC as recommended by leading guidelines. A similar proportion of NPs surveyed younger than 50 (93 percent) reported that CRC screening would be a personal priority when turning 50.

While the majority of NP respondents (79 percent) said they routinely discuss CRC screening with their eligible patients, the survey showed that there is an opportunity to embrace the latest recommended non-invasive CRC screening options.

Almost all NP respondents were familiar with colonoscopy (98 percent) and the fecal blood test (92 percent), while half of NP respondents were familiar with multitarget stool DNA test (Cologuard)–a noninvasive stool DNA test that requires no preparation and can be completed at home.

“Nurse practitioners are leaders in colorectal cancer screening, encouraging their eligible patients to be screened,” said AANP President Joyce Knestrick, PhD, APRN, CFNP, FAANP. “However, only two-thirds of NPs surveyed said that their patients often or always complete CRC screening, with the most common reason for non-compliance being the disruptive nature of test preparation.“

SOURCE: PR Newswire

About The Author

Each year more than 350,000 professionals advance their career with Elite Learning.